MetLife Investment Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Buy |
|
|||||
|
2025
Q1 | $500K | Sell |
|
|||||
|
2024
Q4 | $801K | Buy |
|
|||||
|
2024
Q3 | $792K | Buy |
|
|||||
|
2024
Q2 | $732K | Buy |
|
|||||
|
2024
Q1 | $342K | Hold |
|
|||||
|
2023
Q4 | $240K | Hold |
|
|||||
|
2023
Q3 | $183K | Hold |
|
|||||
|
2023
Q2 | $233K | Hold |
|
|||||
|
2023
Q1 | $207K | Hold |
|
|||||
|
2022
Q4 | $256K | Hold |
|
|||||
|
2022
Q3 | $303K | Hold |
|
|||||
|
2022
Q2 | $295K | Buy |
|
|||||
|
2022
Q1 | $262K | Buy |
|
|||||
|
2021
Q4 | $341K | Hold |
|
|||||
|
2021
Q3 | $353K | Hold |
|
|||||
|
2021
Q2 | $312K | Buy |
|
|||||
|
2021
Q1 | $296K | Buy |
|
|||||
|
2020
Q4 | $167K | Hold |
|
|||||
|
2020
Q3 | $178K | Buy |
|